Wang K - Search Results

1

Synthesis and antitumor activity of bisindolylmaleimide and amino acid ester conjugates.

Wang K, Li XY, Chen XG, Liu ZZ. Wang K, et al. J Asian Nat Prod Res. 2010 Jan;12(1):36-42. doi: 10.1080/10286020903413385. J Asian Nat Prod Res. 2010. PMID: 20390741

2

Design, synthesis and biological evaluation of dipeptides as novel non-covalent 20S proteasome inhibitors.

Yang YJ, Wang K, Yang Y, Lai FF, Chen XG, Xiao ZY. Yang YJ, et al. Among authors: wang k. J Asian Nat Prod Res. 2021 May;23(5):436-451. doi: 10.1080/10286020.2021.1910241. Epub 2021 Apr 12. J Asian Nat Prod Res. 2021. PMID: 33844614

3

Synthesis of N-methyl-bisindolylmaleimide amino acid methyl ester conjugates and cytotoxicity study.

Wang K, Liu ZZ. Wang K, et al. Eur J Med Chem. 2010 Sep;45(9):4175-9. doi: 10.1016/j.ejmech.2010.06.009. Epub 2010 Jun 12. Eur J Med Chem. 2010. PMID: 20598779

4

Synthesis and cytotoxic activities of a series of novel N-methyl-bisindolylmaleimide amide derivatives.

Wang K, Liu ZZ. Wang K, et al. J Asian Nat Prod Res. 2014;16(3):296-303. doi: 10.1080/10286020.2013.877452. J Asian Nat Prod Res. 2014. PMID: 24456252

5

A novel bisindolymaleimide derivative (WK234) inhibits proliferation and induces apoptosis through the protein kinase Cβ pathway, in chronic myelogenous leukemia K562 cells.

Li XY, Li Y, Zhang Y, Wang K, Yuan X, Jin J, Zhang Y, Liu ZZ, Chen XG. Li XY, et al. Among authors: wang k. Leuk Lymphoma. 2011 Jul;52(7):1312-20. doi: 10.3109/10428194.2011.565393. Epub 2011 May 3. Leuk Lymphoma. 2011. PMID: 21534868

6

[Design, synthesis and antitumor activity of sorafenib analogues containing 2-picolinylhydrazide moiety].

Qin AF, Li Y, Song HR, Chen XG, Jin XF, Wang K, Zhang LJ, Huo LC, Feng ZQ. Qin AF, et al. Among authors: wang k. Yao Xue Xue Bao. 2012 Dec;47(12):1623-9. Yao Xue Xue Bao. 2012. PMID: 23460968 Chinese.

7

Design, synthesis and biological evaluation of triaryl compounds as novel 20S proteasome inhibitors.

Yang Y, Wang K, Wu B, Yang Y, Lai F, Chen X, Xiao Z. Yang Y, et al. Among authors: wang k. Bioorg Med Chem Lett. 2020 Nov 1;30(21):127508. doi: 10.1016/j.bmcl.2020.127508. Epub 2020 Aug 24. Bioorg Med Chem Lett. 2020. PMID: 32853683

8

[Synthesis and in vitro cytotoxic activities of sorafenib derivatives].

Wang K, Li Y, Zhang LJ, Yang HZ, Chen XG, Feng ZQ. Wang K, et al. Yao Xue Xue Bao. 2014 May;49(5):639-43. Yao Xue Xue Bao. 2014. PMID: 25151734 Chinese.

9

Design, synthesis, and structure-activity relationship of programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing a benzo[d]isothiazole scaffold.

Chen H, Wang K, Yang Y, Huang X, Dai X, Feng Z. Chen H, et al. Among authors: wang k. Eur J Med Chem. 2021 May 5;217:113377. doi: 10.1016/j.ejmech.2021.113377. Epub 2021 Mar 15. Eur J Med Chem. 2021. PMID: 33770574

10

Design, synthesis, and structure-activity relationship of PD-1/PD-L1 inhibitors with a benzo[d]isoxazole scaffold.

Huang X, Chen H, Dai X, Xu M, Wang K, Feng Z. Huang X, et al. Among authors: wang k. Bioorg Med Chem Lett. 2021 Nov 15;52:128403. doi: 10.1016/j.bmcl.2021.128403. Epub 2021 Oct 2. Bioorg Med Chem Lett. 2021. PMID: 34610423

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,461 results

Search Page

Filters